Open AccessTreatment of Q Fever Endocarditis
Author(s) -
Didier Raoult,
Pierre Houpikian,
Hervé Dupont,
J M Riss,
J Arditi-Djiane,
Philippe Brouqui
Publication year - 1999
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.159.2.167
Subject(s) - medicine , hydroxychloroquine , regimen , doxycycline , surgery , endocarditis , rickettsiosis , antibiotics , gastroenterology , antibody , immunology , disease , covid-19 , serology , infectious disease (medical specialty) , microbiology and biotechnology , biology
Q fever endocarditis, caused by Coxiella burnetii, is fatal in 25% to 60% of patients. Currently, treatment with a long-term tetracycline and quinolone regimen for at least 4 years is recommended, although relapses are frequent.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom